<DOC>
	<DOCNO>NCT00030173</DOCNO>
	<brief_summary>Epothilone D represent one class cytotoxic macrolides capable cause mitotic arrest stabilize tubulin polymerization . Since microtubule essential mitosis , motility , secretion proliferation , observed antitumor effect epothilones attribute ability initiate cell death inhibiting process . Epothilone D demonstrate vitro cytotoxic activity panel human cell line , equipotent paclitaxel . In vivo , Epothilone D also show significant antitumor activity range xenograft model , include paclitaxel-resistant xenograft . Epothilone D potent paclitaxel cell line demonstrate multiple drug resistant activity overexpressing p-glycoprotein .</brief_summary>
	<brief_title>A Trial Evaluate Epothilone D Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Epothilones</mesh_term>
	<criteria>1 . Diagnosis histologically document , advanced stage , primary metastatic adult solid tumor refractory standard therapy curative standard therapy exist . This include limited cancer breast , ovary , head neck , esophagus , lung , gastrointestinal tract , sarcoma . 2 . Evidence radiographically measurable evaluable disease . 1 . Preexisting peripheral neuropathy CTC Grade &gt; 2 due cause . 2 . Documented hypersensitivity reaction ( CTC Grade &gt; 2 ) prior paclitaxel therapy contain Cremophor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Epothilone D</keyword>
	<keyword>tubulin polymerization</keyword>
</DOC>